Kaiser Family Foundation. From 1984 to 1989 she chaired the National Heart, Lung, and Blood Institute advisory committee on AIDS, and from 1988 to 1992 was a member of the WHO Global Commission on AIDS. From 1989 to 1993 she was chairwoman of the U.S. National Commission on AIDS. In 2005 she was elected to a 5-year term on the Board of Trustees of the U.S. Pharmacopeia. She has published on topics in virology, infectious diseases, AIDS, and public policy. She received the distinguished alumna award from Case Western Reserve Medical School in 1993, and in 1994 she shared with Dr. Mathilde Krim the Scientific Freedom and Responsibility award of the American Association for the Advancement of Science. She holds honorary degrees from the University of Medicine and Dentistry of New Jersey (1990), Yale University (1992), Emory University (1993), Oberlin College (1993), Medical College of Pennsylvania (1994), Rutgers University (1994), Case Western Reserve University (1997), State University of New York–Stony Brook (1998), and the University of Wisconsin–Madison (2004).
Karen G. Gervais, Ph.D., director of the Minnesota Center for Health Care Ethics, received her B.A. from Oberlin College and her Ph.D. from the University of Minnesota. A philosophy professor for 18 years, in 1989 she transitioned her career into the field of health care ethics. She served as center associate of the Center for Biomedical Ethics at the University of Minnesota; coordinator of the Minnesota Network for Institutional Ethics Committees; Winifred and Atherton Bean Visiting Chair of Professor of Science, Technology, and Society at Carleton College; Visiting Distinguished Professor of Law and Liberal Studies at Hamline University; and Visiting Associate Professor of Philosophy at St. Olaf College. Dr. Gervais’ scholarly interests include clinical and organizational ethics and health policy, public health ethics, access to health care, health disparities, resource allocation, managed care, community benefit responsibilities of nonprofit health care organizations, ethically informed decision making for persons with dementia, and the definition of death. She has served as ethics and policy consultant for the Office of Technology Assessment, Minnesota Council of Health Plans, Minnesota Medical Association, Hennepin Medical Society, Minnesota Department of Human Services, Minnesota Department of Health, Minnesota Attorney General’s Office, Science Museum of Minnesota, American Association of Health Plans, National Council of State Boards of Nursing, and the National Marrow Donor Program. She also served as an ethics advisor to the Minnesota Commission on End-of-Life Care and is a member of the Minnesota Department of Health’s Task Force on Health and Bioterrorism. She is currently co-investigator of the project, “Ethical and Policy Challenges in Deep Brain Stimulation for Parkinson’s Disease.” In 1987 Dr. Gervais published